COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
Sahar Memar Montazerin (talk | contribs)
No edit summary
Line 26: Line 26:
*Hannah Abude
*Hannah Abude


'''Frequently Asked Inpatient Questions'''
'''Frequently Asked Outpatient Questions'''


'''Hematologic disorders of COVID-19 Team Members'''
'''Hematologic disorders of COVID-19 Team Members'''
Line 49: Line 52:


*Rana Aljebzi
*Rana Aljebzi
*[[User:Neepa Shah|Neepa Shah, M.B.B.S.]]
 





Revision as of 18:33, 10 June 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief:

Cardiovascular Disorders of COVID-19 Team Members


Dermatologic Disorders of COVID-19 Team Members

  • Nuha Shah
  • Hannah Abude

Frequently Asked Inpatient Questions

Frequently Asked Outpatient Questions

Hematologic disorders of COVID-19 Team Members


Nephrologic Disorders of COVID-19 Team Members


Neurologic Disorders and COVID-19 Team Members


Ongoing Clinical Trials of COVID-19 Team Members


Pulmonary Disorders and COVID-19 Team Members

  • Rana Aljebzi


Radiologic Manifestations of COVID-19 Team Members


Other Team Members